CHI Memorial
Approved Hospital Formulary
Epic Issue Reporting
Pharmacy Google Site
AUC CALCULATOR FEEDBACK
Huddle Board
End of Shift Google Form
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warnings
FDA Safety Alerts
Look Alike/Sound Alike
Restricted Drugs
Therapeutic Substitutions
Non-Formulary, Specialty
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
Boards
CHI Memorial
Approved Hospital Formulary
Epic Issue Reporting
Pharmacy Google Site
AUC CALCULATOR FEEDBACK
Huddle Board
End of Shift Google Form
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Black Box Warnings
FDA Safety Alerts
Look Alike/Sound Alike
Restricted Drugs
Therapeutic Substitutions
Non-Formulary, Specialty
Webpage Links
Antineoplastic Agents
abiraterone
ado-trastuzumab
anastrozole
atezolizumab
avelumab
bevacizumab
bevacizumab-awwb
bevacizumab-maly
bicalutamide
bleomycin
blinatumomab
bortezomib
brentuximab vedotin
cabazitaxel
capecitabine
CARBOplatin
carfilzomib
cemiplimab-rwlc
cetuximab
CISplatin
clofarabine
cyclophosphamide
cytarabine
cytarabine liposomal
dacarbazine
daratumumab
dasatinib
DAUNOrubicin
docetaxel
DOXOrubicin
DOXOrubicin Liposomal
durvalumab
enzalutamide
eriBULin
erlotinib
etoposide
exemestane
fludarabine
fluorouracil
flutamide
fulvestrant
gemcitabine
gemtuzumab
goserelin
hydroxyurea
ifosfamide
ipilimumab
letrozole
leuprolide
megestrol
melphalan
mercaptopurine
methotrexate
midostaurin
mitomycin
mitoXANTRONE
necitumumab
nelarabine
ofatumumab
osimertinib
oxaliplatin
paclitaxel
PACLitaxel protein-bound
palbociclib
pegaspargase
pembrolizumab
pertuzumab
ramucirumab
riTUXimab
ruxolitinib
sunitinib
temozolomide
topotecan
trastuzumab
trastuzumab-anns
venetoclax
vinBLAStine
vinCRIStine